Faeth Therapeutics to host virtual KOL event on endometrial cancer multi-nodal inhibition
FTH•Virtual KOL event planned for Oct. 6
Faeth Therapeutics will host a virtual key opinion leader event on Oct. 6, 2026 at 10:00 a.m. ET.
- Discussion to focus on multi-nodal inhibition of the PI3K/AKT/mTOR pathway in endometrial cancer.
- Management plans to review the PIKTOR regimen combining serabelisib with sapanisertib.
